Fig. 2From: A combined 2-D and 3-D QSAR modeling, molecular docking study, design, and pharmacokinetic profiling of some arylimidamide-azole hybrids as superior L. donovani inhibitorsPlot of standardized residual against experimental pIC50Back to article page